Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × OTHER × tipifarnib × Clear all

Phase

Status

Completed 15 Terminated 4 Unknown 2 Withdrawn 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 1

Interventions

Radiotherapy 280 Specimen Handling 276 Magnetic Resonance Spectroscopy 276 pembrolizumab 260 Cyclophosphamide 248 Cisplatin 224 Carboplatin 208 Drug Therapy 198 Blood Specimen Collection 198 Biopsy 166 Gemcitabine 153 Bevacizumab 150 venetoclax 149 Radiosurgery 145 fludarabine 140 Nivolumab 135 Oxaliplatin 134 Capecitabine 132 Paclitaxel 128 Standard of Care 119 Surgical Procedures, Operative 112 Surveys and Questionnaires 108 Fluorouracil 107 Dexamethasone 107 Docetaxel 99 tislelizumab 93 Rituximab 92 Radiation 91 Cytarabine 90 durvalumab 81

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06540963 2026-03-02

Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma

Milton S. Hershey Medical Center

Phase 2 Recruiting

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡